BNTC
Benitec Biopharma Inc.
$13.42
-0.06 (-0.45%)
At close · Jul 10
Market Cap
$461.04M
Shares
34,354,334
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2024
Net Income
-$37.92M
-74.3%
FY2025
Operating Margin
-25441.33%
-983.8pp
FY2023
Diluted EPS
-$1.05
+13.9%
FY2025
Operating Cash Flow
-$23.59M
-21.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| — | — | $0 | $75K | $73K | $59K | $102K | $12.2M | |
| $18.37M | $18.33M | $15.61M | $12.77M | $11.27M | $7.02M | $3M | $4.57M | |
| $28.23M | $23.43M | $6.99M | $6.38M | $6.65M | $6.51M | $5.57M | $4.61M | |
| $55K | $66K | $87K | $136K | $167K | $231K | $190K | $158K | |
| $46.6M | $41.77M | $22.49M | $19.16M | $17.93M | $13.66M | $8.38M | $9.62M | |
| -$46.6M | -$41.77M | -$22.49M | -$19.08M | -$17.85M | -$13.6M | -$8.28M | $2.58M | |
| — | — | — | -25441.33% | -24457.53% | -23044.07% | -8118.63% | 21.17% | |
| -$46.54M | -$41.7M | -$22.4M | -$18.95M | -$17.69M | -$13.37M | -$8.09M | $2.74M | |
| $5.05M | $3.85M | $739K | -$481K | -$354K | -$286K | $7000 | $26K | |
| -$41.54M | -$37.92M | -$21.75M | -$19.56M | -$18.21M | -$13.88M | -$8.27M | $2.61M | |
| — | — | — | -26082.67% | -24942.47% | -23528.81% | -8111.76% | 21.39% | |
| -$41.54M | -$37.92M | -$22.37M | -$19.56M | — | — | — | — | |
| -$41.78M | -$37.86M | -$21.81M | -$19.15M | -$18M | -$13.38M | -$8.36M | $2.08M | |
| USD/shares | — | -$1.05 | -$1.22 | -$14.12 | -$37.88 | -$54.91 | — | — |
| USD/shares | — | -$1.05 | -$1.22 | -$14.12 | -$37.88 | -$54.91 | — | — |
| shares | — | 36.21M | 18.36M | 1.39M | 480.69K | 252.67K | 60.07K | 50.4K |
| shares | — | 36.21M | 18.36M | 1.39M | 480.69K | 252.67K | 60.07K | 50.4K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.05×
EV/EBIT
—
Biotechnology median 25.73×
P/E (TTM)
—
Biotechnology median 7.52×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|---|
| License | $0 | $75,000 | $73,000 | $59,000 | $0 |
| Royalty | — | — | — | — | $93,000 |
| Service | — | — | — | — | $4,000 |